Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Weastfinace Group Inc is a private investment and holding company headquartered in Anaheim, California, that serves as a major strategic shareholder in CN Energy Group Inc. (NASDAQ: CNEY). The company is integrated into the life sciences sector through its control and financing of wood-based activated carbon production, a material that is critical for pharmaceutical manufacturing, chemical purification, and medical dialysis processes. Weastfinace is led by Xinyang Wang, who serves as the CEO and Chairwoman of both Weastfinace and CN Energy Group. The firm plays a central role in the governance and capitalization of enterprises focused on biomass energy and industrial materials used in the healthcare and environmental protection industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Weastfinace Group Inc.